Scroll Top

Health Headlines for Monday, July 2

Next year’s Obamacare: More insurers but steeper prices

Washington Examiner

Health insurers are planning to expand in Obamacare amid rising profits, but the trend is coming at the expense of higher premiums for certain customers.

Read more

The Trump plan to reduce drug prices — are American patients first?

The Hill

Cancer drug prices continue to increase by 10 to 12 percent every year. Spending on cancer drugs doubled in the past five years, and will double again by 2022.

Read more

Finally, Some Answers on the Effects of Medicaid Expansion

New York Times

The Medicaid logjam appears to be breaking.

Read more

Emergency Rooms Run Out of Vital Drugs, and Patients Are Feeling It

New York Times

George Vander Linde tapped a code into the emergency room’s automated medicine cabinet. A drawer slid open and he flipped the lid, but found nothing inside.

Read more

This drug went from $40 to $39,000: Medicare spent $2 billion for one drug as the manufacturer paid doctors millions

Fox 8

More than 80% of doctors who filed Medicare claims in 2016 for H.P. Acthar Gel — a drug best known for treating a rare infant seizure disorder — received money or other perks from the drugmakers, according to a CNN analysis of publicly identified prescribers.

Read more

Excellus BCBS grants Community Health Awards

Rochester First

Groups that help refugees, inner city youths, and others in the Rochester area will be able to expand their programs, thanks to awards from Excellus Blue Cross Blue Shield.

Read more

The IRS Can Save American Health Care

Wall Street Journal (Subscription Required)

Health care is fast becoming an unsustainable expense for American families. This year the total cost of insurance for the typical family of four eclipsed $28,000, according to the Milliman Medical Index. Rising insurance premiums are also eroding worker compensation, as companies shift increased costs to employees.

Read more